Organization | University of Nigeria

University of Nigeria Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial

1998

NCT01409837

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2011

Timeline

NOW

Alternative names

College of Medicine, University of Nigeria , Enugu Campus | University of Nigeria, Enugu Campus | University Of Nigeria Teaching Hospital | University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu

Active Ingredients

Drugs in Phase 4 Trials (6)

amlodipine (norvasc) (1 trial)

bisoprolol (zebeta) (1 trial)

hydrochlorothiazide (esidrix) (1 trial)

pyrimethamine (daraprim) (1 trial)

sulfadoxine (1 trial)

valsartan (diovan) (1 trial)

Drugs in Phase 2 Trials (1)

lisinopril (zestril) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Infertility (Phase 2)

Oligospermia (Phase 2)

Pregnancy Complications (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 3
# of Trial APIs: 7